Phase 2b Study of the Clinical Efficacy and Safety of Collagenase Clostridium Histolyticum in Patients With Peyronie Disease

The Journal of Urology, 05/10/2012

Collagenase clostridium histolyticum treatment was well tolerated. The authors noted significant improvement in penile curvature and patient reported outcome symptom bother scores, suggesting that this may be a safe, nonsurgical alternative for Peyronie disease.

Print Article Summary Cat 2 CME Report